Dynavax Technologies | DVAX - EPS Earnings Per Share


Dynavax Technologies reported $0.21 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.



Eps Change Date
AbbVie USD 2.71 0.85 Dec/2025
Adma Biologics USD 0.15 0.01 Sep/2025
Agenus USD -1.03 1.01 Mar/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Glaxosmithkline GBP 0.72 0.37 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025